An iridium( iii )-based irreversible protein–protein interaction inhibitor of BRD4 as a potent anticancer agent
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
This is the first report of a metal complex that targets the BRD4-acylated histone protein-protein interaction (PPI).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent improvements in structural biology and chemical reactivity have enabled the design and development of potent and selective covalent PPI inhibitors.”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [38]
Experimental — accuracy not yet measuredIn the citing paper
“Aided by recent advancements in structural biology and chemistry, covalent inhibitors have emerged as a potentially effective approach towards PPI inhibition [37, 38].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
The Role of Chromatin during Transcription
Li, B., Carey, M., & Workman, J. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.015 · Cited by 3,533
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564
Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D., & Patel, D. J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1338 · Cited by 1,418
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
c-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L., & Sims, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108190108 · Cited by 1,110
Multivalent engagement of chromatin modifications by linked binding modules
Ruthenburg, A. J., Li, H., Patel, D. J., & David Allis, C. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2298 · Cited by 1,013
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Regulation of nucleosome dynamics by histone modifications
Zentner, G. E., & Henikoff, S. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2470 · Cited by 923
Coller, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
Bromodomain: an acetyl‐lysine binding domain
Zeng, L., & Zhou, M.-M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03309-9 · Cited by 746
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Trondl, R., Heffeter, P., Kowol, C. R., Jakupec, M. A., Berger, W., & Keppler, B. K. (2014) · Chem. Sci. · doi:10.1039/c3sc53243g · Cited by 675
Accelerated Luminophore Discovery through Combinatorial Synthesis
Lowry, M. S., Hudson, W. R., Pascal, R. A., & Bernhard, S. (2004) · Journal of the American Chemical Society · doi:10.1021/ja047156+ · Cited by 491
Targeting proteins with metal complexes
Meggers, E. (2009) · Chemical Communications · doi:10.1039/b813568a · Cited by 450
Bioactive Luminescent Transition‐Metal Complexes for Biomedical Applications
Ma, D., He, H., Leung, K., Chan, D. S., & Leung, C. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208414 · Cited by 388
Self-citationA Nonemissive Iridium(III) Complex That Specifically Lights-Up the Nuclei of Living Cells
Li, C., Yu, M., Sun, Y., Wu, Y., Huang, C., & Li, F. (2011) · Journal of the American Chemical Society · doi:10.1021/ja202344c · Cited by 373
Designing organometallic compounds for catalysis and therapy
Noffke, A. L., Habtemariam, A., Pizarro, A. M., & Sadler, P. J. (2012) · Chemical Communications · doi:10.1039/c2cc30678f · Cited by 370
Platinum Drug Distribution in Cancer Cells and Tumors
Klein, A. V., & Hambley, T. W. (2009) · Chemical Reviews · doi:10.1021/cr9001066 · Cited by 351
Yang, Z., He, N., & Zhou, Q. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01020-07 · Cited by 347
Brd4 Marks Select Genes on Mitotic Chromatin and Directs Postmitotic Transcription
Dey, A., Nishiyama, A., Karpova, T., McNally, J., & Ozato, K. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-05-0380 · Cited by 316
Enzyme inhibition by metal complexes: concepts, strategies and applications
Kilpin, K. J., & Dyson, P. J. (2013) · Chemical Science · doi:10.1039/c3sc22349c · Cited by 242
Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase Inhibitors
Feng, L., Geisselbrecht, Y., Blanck, S., Wilbuer, A., Atilla-Gokcumen, G. E., Filippakopoulos, P., Kräling, K., Celik, M. A., Harms, K., Maksimoska, J., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1112996 · Cited by 239
BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy
Segura, M. F., Fontanals-Cirera, B., Gaziel-Sovran, A., Guijarro, M. V., Hanniford, D., Zhang, G., González-Gomez, P., Morante, M., Jubierre, L., Zhang, W., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0122-t · Cited by 239
Ma, D., Wong, W., Chung, W., Chan, F., So, P., Lai, T., Zhou, Z., Leung, Y., & Wong, K. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705319 · Cited by 235
Self-citationTargeting Nucleus DNA with a Cyclometalated Dipyridophenazineruthenium(II) Complex
Huang, H., Zhang, P., Yu, B., Chen, Y., Wang, J., Ji, L., & Chao, H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501095r · Cited by 230
Metal complexes in medicine with a focus on enzyme inhibition
Che, C.-M., & Siu, F.-M. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.11.015 · Cited by 224
Ember, S. W. J., Zhu, J.-Y., Olesen, S. H., Martin, M. P., Becker, A., Berndt, N., Georg, G. I., & Schönbrunn, E. (2014) · ACS Chemical Biology · doi:10.1021/cb500072z · Cited by 221
Meng, X., Leyva, M. L., Jenny, M., Gross, I., Benosman, S., Fricker, B., Harlepp, S., Hébraud, P., Boos, A., Wlosik, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4408 · Cited by 208
The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.
Kratz, F., Hartmann, M., Keppler, B., & Messori, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41984-3 · Cited by 204
Bromodomain 4 activation predicts breast cancer survival
Crawford, N. P. S., Alsarraj, J., Lukes, L., Walker, R. C., Officewala, J. S., Yang, H. H., Lee, M. P., Ozato, K., & Hunter, K. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710331105 · Cited by 189
Chung, C.-W., Dean, A. W., Woolven, J. M., & Bamborough, P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201320w · Cited by 188
On the Biological Properties of Alkynyl Phosphine Gold(I) Complexes
Meyer, A., Bagowski, C. P., Kokoschka, M., Stefanopoulou, M., Alborzinia, H., Can, S., Vlecken, D. H., Sheldrick, W. S., Wölfl, S., & Ott, I. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202939 · Cited by 187
You bet-cha a novel family of transcriptional regulators
Florence, B. (2001) · Frontiers in Bioscience · doi:10.2741/a663 · Cited by 176
Emerging protein targets for metal-based pharmaceutical agents: An update
de Almeida, A., Oliveira, B. L., Correia, J. D. G., Soveral, G., & Casini, A. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.01.031 · Cited by 167
A Metal‐Based Inhibitor of Tumor Necrosis Factor‐α
Leung, C., Zhong, H., Yang, H., Cheng, Z., Chan, D. S., Ma, V. P., Abagyan, R., Wong, C., & Ma, D. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202937 · Cited by 164
Self-citationHartinger, C. G., Groessl, M., Meier, S. M., Casini, A., & Dyson, P. J. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35532b · Cited by 157
Dömötör, O., Hartinger, C. G., Bytzek, A. K., Kiss, T., Keppler, B. K., & Enyedy, É. A. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0944-6 · Cited by 145
Luigi Messori, A., Orioli, P., Vullo, D., Alessio, E., & Iengo, E. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01121.x · Cited by 143
Identifying Genes Regulated in a Myc-dependent Manner
Watson, J. D., Oster, S. K., Shago, M., Khosravi, F., & Penn, L. Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201493200 · Cited by 130
Antagonizing STAT3 Dimerization with a Rhodium(III) Complex
Ma, D., Liu, L., Leung, K., Chen, Y., Zhong, H., Chan, D. S., Wang, H. D., & Leung, C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201404686 · Cited by 122
Self-citationPiccioli, F., Sabatini, S., Luigi Messori, A., Orioli, P., Hartinger, C. G., & Keppler, B. K. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.04.002 · Cited by 83
Brd4 and HEXIM1: Multiple Roles in P-TEFb Regulation and Cancer
Chen, R., Yik, J. H. N., Lew, Q. J., & Chao, S. (2014) · BioMed Research International · doi:10.1155/2014/232870 · Cited by 81
Anand, R., Maksimoska, J., Pagano, N., Wong, E., Gimotty, P. A., Diamond, S. L., Meggers, E., & Marmorstein, R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8005806 · Cited by 78
Leonidova, A., Pierroz, V., Adams, L. A., Barlow, Ν., Ferrari, S. M., Graham, B., & Gasser, G. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500158w · Cited by 75
Lawlor, E. R., Soucek, L., Brown-Swigart, L., Shchors, K., Bialucha, C. U., & Evan, G. I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3826 · Cited by 74
Timerbaev, A. R., Foteeva, L. S., Rudnev, A. V., Abramski, J. K., Pawlak, K., Hartinger, C. G., Jarosz, M., & Keppler, B. K. (2007) · Electrophoresis · doi:10.1002/elps.200600707 · Cited by 47
Structure of anticancer ruthenium half-sandwich complex bound to glycogen synthase kinase 3β
Atilla‐Gokcumen, G. E., Costanzo, L. D., & Meggers, E. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-010-0699-x · Cited by 47
Gene therapy for carcinoma of the breast
Stoff‐Khalili, M. A., Dall, P., & Curiel, D. T. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700929 · Cited by 46
Webb, M. I., & Walsby, C. J. (2015) · Dalton Transactions · doi:10.1039/c5dt02021b · Cited by 41
Organometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors
Blanck, S., Cruchter, T., Vultur, A., Riedel, R., Harms, K., Herlyn, M., & Meggers, E. (2011) · Organometallics · doi:10.1021/om200366r · Cited by 41
Pyridocarbazole‐Rhodium(III) Complexes as Protein Kinase Inhibitors
Dieckmann, S., Riedel, R., Harms, K., & Meggers, E. (2012) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201101175 · Cited by 38
Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition
Blanck, S., Geisselbrecht, Y., Kräling, K., Middel, S., Mietke, T., Harms, K., Essen, L., & Meggers, E. (2012) · Dalton Transactions · doi:10.1039/c2dt30940h · Cited by 27
A metal-based tumour necrosis factor-alpha converting enzyme inhibitor
Leung, C., Liu, L., Lu, L., He, B., Kwong, D. W. J., Wong, C., & Ma, D. (2015) · Chemical Communications · doi:10.1039/c4cc09251a · Cited by 27
Self-citationCyclometalated phenylquinoline rhodium complexes as protein kinase inhibitors
Mollin, S., Blanck, S., Harms, K., & Meggers, E. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.04.035 · Cited by 25
P-donor ligand containing ruthenium half-sandwich complexes as protein kinase inhibitors
Streu, C. N., Feng, L., Carroll, P. J., Maksimoska, J., Marmorstein, R., & Meggers, E. (2011) · Inorganica Chimica Acta · doi:10.1016/j.ica.2011.07.032 · Cited by 11
Research works printed but not linked: 3
- Florence, 2001, Front. Biosci., 6, d1008
- Chung, 2012, Drug Discovery Today: Ther. Strategies, 9, e111
- Chen, 2014, BioMed Res. Int., 2014, 232870
Cited by
Alessio, E. (2017) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201600986 · Cited by 388
Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy
Zamora, A., Vigueras, G., Rodríguez, V., Santana, M. D., & Ruiz, J. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.01.010 · Cited by 345
Ran, X., & Gestwicki, J. E. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.06.004 · Cited by 263
Potential biomedical applications of marine algae
Wang, H.-M. D., Li, X.-C., Lee, D.-J., & Chang, J.-S. (2017) · Bioresource Technology · doi:10.1016/j.biortech.2017.05.198 · Cited by 217
Sohrabi, M., Saeedi, M., Larijani, B., & Mahdavi, M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113308 · Cited by 206
Metadata
- Authors
- Zhong, H.-J., Lu, L., Leung, K.-H., Wong, C. C. L., Peng, C., Yan, S.-C., Ma, D.-L., Cai, Z., David Wang, H.-M., & Leung, C.-H.
- Affiliations
- University of Macau (MO)
- Hong Kong Baptist University (HK)
- Chinese Academy of Sciences (CN)
- Hong Kong Polytechnic University (HK)
- Department of Fragrance and Cosmetic Science
- Corresponding author
- Ma, Dik-Lung
- Cai, Zongwei
- Leung, Chung-Hang
- ORCID
- Venue
- Chemical Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2015
- Volume
- 6
- Issue
- 10
- Pages
- 5400-5408
- ISSN
- 2041-6520 (ISSN-L)
- 2041-6539
- PMC
- PMC5510529
- OpenAlex
- W4247705075
- Cited by
- 138
- References
- 59
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 3 · 2023: 7 · 2022: 8 · 2021: 8 · 2020: 15 · 2019: 11 · 2018: 12 · 2017: 30 · 2016: 27 · 2015: 4
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Chemical Science (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HKBU Institutional Repository (Hong Kong Baptist University) (submittedVersion, other-oa)
- PolyU Institutional Research Archive (Hong Kong Polytechnic University) (submittedVersion)
- Funders
- Hong Kong Baptist University (FRG2/14-15/004)
- Health and Medical Research Fund (HMRF/13121482, HMRF/14130522)
- Science and Technology Development Fund (103/2012/A3, 098/2014/A2)
- Universidade de Macau (MYRG091(Y3-L2)-ICMS12-LCH, MYRG2015-00137-ICMS-QRCM, MRG023/LCH/2013/ICMS)
- The Research Grants Council, University Grants Committee, Hong Kong (HKBU/201811, HKBU/204612, HKBU/201913)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- iridium(III) complexes, BRD4, protein-protein interaction inhibitors, epigenetic inhibitors, anticancer agents, melanoma, metal-based anticancer agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.